Fig. 11From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosisGraphic abstract. There were severe bacterial dysbiosis and moderate fungal dysbiosis in the colon of type 2 SBS rats, while GLP-2 might have potential therapeutic effect of these dysbiosisBack to article page